Advisors Asset Management, Inc. Ani Pharmaceuticals Inc Transaction History

Advisors Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$23.69 - $31.47 $4,974 - $6,608	-210 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $8,072 - $10,128	-306 Reduced 59.3%	210 $6,000
Q2 2020 Aug 12, 2020	SELL	$29.93 - $50.1 $419 - $701	-14 Reduced 2.64%	516 $17,000
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $1,669 - $3,692	-55 Reduced 9.4%	530 $22,000
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $1,558 - $2,235	28 Added 5.03%	585 $36,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $15,204 - $20,066	235 Added 72.98%	557 $41,000
Q2 2019 Aug 14, 2019	BUY	$67.77 - $82.2 $21,821 - $26,468	322 New	322 $26,000

211

19.2M

3.4K

10.8K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $950M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.